Medicine and Dentistry
Human Immunodeficiency Virus
100%
Wart Virus
100%
Somatomedin
100%
Highly Active Antiretroviral Therapy
81%
Somatomedin C
81%
Synapsin II
72%
Protein Binding
72%
Disease
27%
Neoplasm
27%
Disease Exacerbation
18%
Antimitotic Agent
18%
C-Peptide
9%
Cross Sectional Study
9%
Somatomedin B
9%
Somatomedin Binding Protein
9%
Cell Survival
9%
Antiapoptotic
9%
Cell Proliferation
9%
Immune System
9%
Lymphocyte
9%
Cohort Effect
9%
T-Helper Cell
9%
Pharmacology, Toxicology and Pharmaceutical Science
Human Papillomavirus
100%
Somatomedin
100%
HIV
100%
Somatomedin C
81%
Binding Protein
72%
Synapsin II
72%
Neoplasm
27%
Disease
27%
Disease Exacerbation
18%
Antimitotic Agent
18%
Antiapoptotic
9%
Cross-Sectional Study
9%
Somatomedin B
9%
C Peptide
9%
Epidemiology
9%
Somatomedin Binding Protein
9%
Keyphrases
Growth Factors
50%
High-risk Human Papillomavirus (HR-HPV)
50%
Insulin-like
50%
IGF-binding protein-3
20%
Highly Active Antiretroviral Therapy (HAART)
20%
Oncogenic Human Papillomavirus
7%
Natural History
5%
Untapped Potential
5%
HIV-positive
5%
Sexually Transmitted Virus
5%
Antimitotic
5%
Thymus Regeneration
5%
Cervical Neoplasia
5%
Specimen Data
5%
HIV Disease
5%
HIV Disease Progression
5%